PharmExec Direct:
Having trouble viewing this e-mail? Click here.
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Advertise With Us | Visit PharmExec.com | PRINT SUBSCRIBE | DIGITAL SUBSCRIBE
 November 25, 2015 | ISSUE NUMBER 428 VOL 4
Top Story
FDA Seeks to Advance Research on Cellular & Gene Therapies
There’s renewed optimism in the biomedical research community that years of effort finally may begin to pay off for developing cutting-edge gene and cellular treatments for debilitating and life-threatening conditions. FDA seeks to clarify policies for regulating cellular and tissue-based products, with a public meeting scheduled for April 26, 2016. Jill Wechsler reports
...Read more
Interview
A Fireside Chat with Brent Saunders, Allergan CEO
At this year's Summit on “Emerging Strategic, Financial and Shareholder Issues” on November 3, Peter Young sat down with Brent Saunders, CEO of Allergan, for a fireside chat about Saunders’ early entrepreneurial years, his career in the industry, and some of his business philosophies
...Read more
Strategy
Tech Giants Collaborate and Disrupt in Life Sciences Industry
As tech giants, enter the life sciences industry, healthcare companies should adapt their business model and embark with these new players on a more ambitious, personalized, and preventive healthcare strategy, writes Anaïs Frappé
...Read more
Special Feature
Pharm Exec's Pipeline Report 2016
Will a drug pipeline harvest full of treatments founded on strong science, supportive regulation, and unmet medical need offer solace to shareholders and the promise of a reputational rebound? Will presidential politics add to the pressures on drug pricing, with a sour coda to the old refrain, “in the US, the market decides?” Casey McDonald reports
...Read more
//The newly appointed Chief Financial Officer at Array BioPharma (Boulder, CO) is to step down after three months on the job. Patricia Henahan plans to resign from her position on December 17.//Abcodia (Cambridge, UK, and Boston, MA) announced the appointment of Richard A. “Dick” Sandberg to its Board of Directors.//Purdue Pharma (Stamford, CT) announced the appointment of Alan W. Dunton, M.D., as Senior Vice President of Research & Development.//CytoDyn (Vancouver, WA) hired Nitya G. Ray, Ph.D., as Senior Vice President, Manufacturing.//
December 2–3: Publication Planning
Philadelphia, PA.


January 28–29, 2016: 11th Summit on Biosimilars
Alexandria, VA.


February 18–19, 2016: Bio/Pharma Social Media and Digital Platforms
Philadelphia, PA.
Follow Pharm Exec on Twitter
Follow Pharm Exec on Linkedin

Quick Links

Califf Sidesteps Drug Pricing Complaints from Senate

DIA: Listening and Learning from Patients

Pharm Exec eBooks: Patient Centric Approach to Product Commercialization

The Push for a Pull Supply Chain